Search | Page 5 | Aplastic Anemia and MDS International Foundation

Search

Search results

  1. Advances in antiviral drug cuts infection post SCT

    ... the safety of donor stem cell transplants, a major clinical trial led by researchers at Dana-Farber Cancer Institute and Brigham and ...

    Article last updated 02/23/2017 - 7:26am.

  2. Like AAMDSIF, HHS now provides more info on clinical trials

    ... HHS takes steps to provide more information about clinical trials to the public ... or privately supported, and help us honor our commitments to trial participants, who do so much to help society advance knowledge and ...

    Article last updated 11/22/2016 - 2:05pm.

  3. The value of survival gains in myelodysplastic syndromes.

    ... and End Results Program (SEER) registry, clinical trial evidence for MDS therapies, and claims data. METHODS: We used ...

    Research Article last updated 02/21/2017 - 11:36am.

  4. PACCT+ Patient Committee Holds First Meeting

    ... On September 24, the AAMDSIF Patient Advisory Council on Clinical Trials (PACCT+) members met in Arlington, Virginia for an orientation ... members, and learn from two experts about clinical trial design and the state of current bone marrow failure (BMF) ...

    Article last updated 01/23/2017 - 2:12pm.

  5. New positive results for GVHD treatment

    ... of stem cell transplant , findings from a small clinical trial show. Patients in the trial had blood cancers and were ...

    Article last updated 01/12/2017 - 11:10am.

  6. Oncologists tell the backstory of informed consent

    ... worsens in medical research. Before you can enroll in a clinical trial of a cancer drug, we’ll hand you a 25-page document that describes ...

    Article last updated 03/02/2017 - 10:03am.

  7. Outcome of patients treated for myelodysplastic syndromes without deletion 5q after failure of lenalidomide therapy

    ... remains relatively prolonged, though with a wide range. Clinical trial participation remains the recommendation for these patients even if ...

    Research Article last updated 02/21/2017 - 9:43am.

  8. Strong results for SAA patients at Johns Hopkins

    ... and an author of the report. Results of the small clinical trial have already prompted the organization of a larger national trial ...

    Article last updated 02/07/2017 - 11:05am.

  9. Phase 2, randomized, double-blind study of pracinostat in combination with azacitidine in patients with untreated, higher risk myelodysplastic syndromes

    ... A phase 2 randomized, placebo -controlled clinical trial of azacitidine and pracinostat was conducted in patients who had ...

    Research Article last updated 02/03/2017 - 11:12am.

  10. A phase 2 trial of high dose lenalidomide in patients with relapsed/refractory higher-risk myelodysplastic syndromes and acute myeloid leukaemia with trilineage dysplasia

    ... but there is limited data in the RR setting. This phase II trial included patients with RR HR-MDS or AML-TD at 2 doses of lenalidomide (15 ... ≥1 year. The study was terminated due to lack of robust clinical activity. In conclusion, lenalidomide at 15 mg is ineffective in RR ...

    Research Article last updated 11/02/2016 - 9:17am.